본문 바로가기

Neuroprotective effects of paeonia lactiflora and its active compound paeoniflorin against Aβ25-35-induced neurotoxicity in SH-SY5Y cells

문서 유형
연구출판물 · 학술지 논문
등재
KCIScopus
저널 순위
Scopus Q4KCI Q2
저널
Journal of Applied Biological Chemistry64(2) · pp.105 · 2021
피인용
Scopus 1KCI 0
FWCI (Scopus)
0.07
ISSN
1976-0442

저자

  1. 남미나제1저자Department of Food Science and Nutrition & Kimchi Research Institute, Pusan National University, Busan, 46241, Republic of Korea
  2. 김지현Department of Food Science and Nutrition & Kimchi Research Institute, Pusan National University, Busan, 46241, Republic of Korea
  3. 이아영교신저자Department of Food Science, Gyeongnam National University of Science and Technology, Jinju, 52725, Republic of Korea
  4. 조은주교신저자Department of Food Science and Nutrition & Kimchi Research Institute, Pusan National University, Busan, 46241, Republic of Korea

초록

© The Korean Society for Applied Biological Chemistry 2021.Excessive accumulation of the amyloid beta (Aβ) peptide has been implicated in the pathogenesis of Alzheimer’s disease (AD). Paeonia lactiflora (PL) has been used in treatments of several conditions such as inflammation, arthritis, and cognitive impairment. The purpose of this study was to investigate the neuroprotective effect and mechanisms of PL and its active compound, paeoniflorin (PF), on Aβ25-35-induced neurotoxicity in SH-SY5Y cells. We evaluated cell viability, lactate dehydrogenase (LDH) release and reactive oxygen species (ROS) production. Furthermore, underlying mechanism of PL and PF on the regulation of amyloidogenic pathway was analyzed by Western blotting. In our results, Aβ25-35-induced neuronal cell loss was observed, whereas treatment with PL (10, 50, and 100 μg/mL) and PF (1, 5, and 10 μg/mL) significantly elevated the cell viability, and decreased LDH release and ROS production. In addition, exposure of SH-SY5Y cells to Aβ25-35 significantly increased the protein levels of amyloid precursor protein (APP)-C-terminal fragment β, β-site APP-cleaving enzyme, and presenilin-1 and-2. However, treatment with PL and PF inhibited the amyloidogenic pathway via the down-regulation of those protein expressions. Taken together, our results indicate that PL, and its active compound PF, could protect SH-SY5Y cells against Aβ25-35induced cell neurotoxicity by attenuating LDH release and ROS production, and these effects may be attributed to regulation of amyloidogenic pathway-related protein expression. In conclusion, PL and PF could be a potential to prevent neurodegenerative disorders such as AD.

키워드

Alzheimer’s diseaseAmyloid betaNeuronalPaeoniaPaeoniflorin

식별자

Scopus EID
2-s2.0-85109470136
KCI
ART002725886